Wong JC, Shiuey EJ, Razeghinejad R, Shukla AG, et al. The effectiveness and tolerability of fixed-dose combination netarsudil
0.02%/latanoprost 0.005% at a tertiary glaucoma center. Graefes Arch Clin Exp Ophthalmol 2022 Jul 29. pii: 10.1007/s00417-022-05780.
PMID: 35904596